Clinical trial
An Open-label, Non-randomized, Single-arm Study to Investigate the Mechanism(s)…
NCT00144261 · Boehringer Ingelheim, Industry · Completed
Key facts
| NCT number | NCT00144261 |
|---|---|
| Title | An Open-label, Non-randomized, Single-arm Study to Investigate the Mechanism(s) by Which Nevirapine Increases Plasma HDL in HIV+ Subjects |
| Official title | An Open-label, Non-randomized, Single-arm Study, to Investigate the Mechanism(s) by Which Nevirapine Increases Plasma High Density Lipoproteins Concentration in HIV+ Subjects Treated With VIRAMUNE® Tablets |
| Lead sponsor | Boehringer Ingelheim, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | HIV Infections, Metabolism, Lipids |
| Intervention type | Drug |
| Interventions | nevirapine |
| Enrollment | 15 |
| Start date | Nov 1, 2003 |
| Primary completion | Dec 1, 2006 |
| First posted | Sep 5, 2005 |
| Last update posted | Jan 31, 2025 |
| Countries | Netherlands, United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: